Beth Rogozinski

Beth Rogozinski is the Chief Executive Officer of Oncoustics, a company focused on advanced AI solutions for non-invasive disease surveillance, diagnostics, and treatment monitoring. In addition to leading Oncoustics since January 2018, Beth serves as an advisor to Modality.AI and has held several independent board director roles, including positions at UnitedHealth Group, Mentia, Inc., and Koa Health. Beth is also a senior advisor at the National Mental Health Innovation Center and an advisor at Neolth Inc. and UCSF Entrepreneurship Center, where support for health innovation is provided. Additionally, Beth is the CEO of Signal 2 Health, a firm dedicated to advancing healthcare innovation through digital tools. Beth holds an MBA in Marketing and Management from San Francisco State University.